Matches in SemOpenAlex for { <https://semopenalex.org/work/W1781153995> ?p ?o ?g. }
- W1781153995 endingPage "20" @default.
- W1781153995 startingPage "2014" @default.
- W1781153995 abstract "Encouraged by the results of 131I-Lym-1 therapy trials for patients with B-cell non-Hodgkin's lymphoma (NHL), this phase I/II clinical trial of 67Cu-2IT-BAT-Lym-1 was conducted in an effort to further improve the therapeutic index of Lym-1-based radioimmunotherapy. Lym-1 is a mouse monoclonal antibody that preferentially targets malignant lymphocytes. 67Cu has beta emissions comparable to those of 131I but has gamma emissions more favorable for imaging. The macrocyclic chelating agent 1,4,7,11-tetraazacyclotetradecane-N,N',N,N'-tetraacetic acid binds 67Cu tightly to form a stable radioimmunoconjugate in vivo.All 12 patients had stage III or IV NHL that had not responded to standard therapy; 11 had intermediate- or high-grade NHL. At 4-wk intervals, patients received up to four doses of 67Cu-2IT-BAT-Lym-1, 0.93 or 1.85-2.22 GBq/m2 (25 or 50-60 mCi/m2), with the lower dose used when NHL was detected in the bone marrow.67Cu-2IT-BAT-Lym-1 provided good imaging of NHL and favorable radiation dosimetry. The mean radiation ratios of tumor to body and tumor to marrow were 28:1 and 15:1, respectively. Tumor-to-lung, -kidney and -liver radiation dose ratios were 7.4:1, 5.3:1 and 2.6: 1, respectively. This 67Cu-2IT-BAT-Lym-1 trial for patients with chemotherapy-resistant NHL had a response rate of 58% (7/12). No significant nonhematologic toxicity was observed. Hematologic toxicity, especially thrombocytopenia, was dose limiting.67Cu remains an option for future clinical trials. This study established 67Cu-2IT-BAT-Lym-1 as a safe, effective treatment for patients with NHL." @default.
- W1781153995 created "2016-06-24" @default.
- W1781153995 creator A5012058776 @default.
- W1781153995 creator A5015083869 @default.
- W1781153995 creator A5032382667 @default.
- W1781153995 creator A5038808449 @default.
- W1781153995 creator A5043106959 @default.
- W1781153995 creator A5044505402 @default.
- W1781153995 creator A5046589665 @default.
- W1781153995 creator A5059680487 @default.
- W1781153995 creator A5061018141 @default.
- W1781153995 creator A5085541150 @default.
- W1781153995 date "1999-12-01" @default.
- W1781153995 modified "2023-10-03" @default.
- W1781153995 title "A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma." @default.
- W1781153995 cites W1513397279 @default.
- W1781153995 cites W1759514589 @default.
- W1781153995 cites W1796578416 @default.
- W1781153995 cites W1804006763 @default.
- W1781153995 cites W1869307723 @default.
- W1781153995 cites W1946026995 @default.
- W1781153995 cites W1986478975 @default.
- W1781153995 cites W2004051439 @default.
- W1781153995 cites W2010900351 @default.
- W1781153995 cites W2023760011 @default.
- W1781153995 cites W2036361071 @default.
- W1781153995 cites W2053344913 @default.
- W1781153995 cites W2066610908 @default.
- W1781153995 cites W2084377890 @default.
- W1781153995 cites W2109741265 @default.
- W1781153995 cites W2124799613 @default.
- W1781153995 cites W2133957468 @default.
- W1781153995 cites W2163032910 @default.
- W1781153995 cites W2164532418 @default.
- W1781153995 cites W2414631060 @default.
- W1781153995 cites W2417659190 @default.
- W1781153995 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10616879" @default.
- W1781153995 hasPublicationYear "1999" @default.
- W1781153995 type Work @default.
- W1781153995 sameAs 1781153995 @default.
- W1781153995 citedByCount "21" @default.
- W1781153995 countsByYear W17811539952012 @default.
- W1781153995 countsByYear W17811539952014 @default.
- W1781153995 countsByYear W17811539952018 @default.
- W1781153995 countsByYear W17811539952020 @default.
- W1781153995 countsByYear W17811539952022 @default.
- W1781153995 countsByYear W17811539952023 @default.
- W1781153995 crossrefType "journal-article" @default.
- W1781153995 hasAuthorship W1781153995A5012058776 @default.
- W1781153995 hasAuthorship W1781153995A5015083869 @default.
- W1781153995 hasAuthorship W1781153995A5032382667 @default.
- W1781153995 hasAuthorship W1781153995A5038808449 @default.
- W1781153995 hasAuthorship W1781153995A5043106959 @default.
- W1781153995 hasAuthorship W1781153995A5044505402 @default.
- W1781153995 hasAuthorship W1781153995A5046589665 @default.
- W1781153995 hasAuthorship W1781153995A5059680487 @default.
- W1781153995 hasAuthorship W1781153995A5061018141 @default.
- W1781153995 hasAuthorship W1781153995A5085541150 @default.
- W1781153995 hasConcept C126322002 @default.
- W1781153995 hasConcept C159654299 @default.
- W1781153995 hasConcept C19831878 @default.
- W1781153995 hasConcept C203014093 @default.
- W1781153995 hasConcept C2776146153 @default.
- W1781153995 hasConcept C2778476748 @default.
- W1781153995 hasConcept C2779338263 @default.
- W1781153995 hasConcept C2780007613 @default.
- W1781153995 hasConcept C2780035454 @default.
- W1781153995 hasConcept C29730261 @default.
- W1781153995 hasConcept C2989005 @default.
- W1781153995 hasConcept C509974204 @default.
- W1781153995 hasConcept C542903549 @default.
- W1781153995 hasConcept C71924100 @default.
- W1781153995 hasConcept C90924648 @default.
- W1781153995 hasConcept C98274493 @default.
- W1781153995 hasConceptScore W1781153995C126322002 @default.
- W1781153995 hasConceptScore W1781153995C159654299 @default.
- W1781153995 hasConceptScore W1781153995C19831878 @default.
- W1781153995 hasConceptScore W1781153995C203014093 @default.
- W1781153995 hasConceptScore W1781153995C2776146153 @default.
- W1781153995 hasConceptScore W1781153995C2778476748 @default.
- W1781153995 hasConceptScore W1781153995C2779338263 @default.
- W1781153995 hasConceptScore W1781153995C2780007613 @default.
- W1781153995 hasConceptScore W1781153995C2780035454 @default.
- W1781153995 hasConceptScore W1781153995C29730261 @default.
- W1781153995 hasConceptScore W1781153995C2989005 @default.
- W1781153995 hasConceptScore W1781153995C509974204 @default.
- W1781153995 hasConceptScore W1781153995C542903549 @default.
- W1781153995 hasConceptScore W1781153995C71924100 @default.
- W1781153995 hasConceptScore W1781153995C90924648 @default.
- W1781153995 hasConceptScore W1781153995C98274493 @default.
- W1781153995 hasIssue "12" @default.
- W1781153995 hasLocation W17811539951 @default.
- W1781153995 hasOpenAccess W1781153995 @default.
- W1781153995 hasPrimaryLocation W17811539951 @default.
- W1781153995 hasRelatedWork W1569354626 @default.
- W1781153995 hasRelatedWork W1933173754 @default.
- W1781153995 hasRelatedWork W1970641137 @default.
- W1781153995 hasRelatedWork W2062678527 @default.